Apyx Medical Corporation (APYX)
USD 0.88
(-2.22%)
USD 0.88
(-2.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 52.34 Million | 44.51 Million | 48.51 Million | 27.71 Million | 28.15 Million | 16.68 Million |
| Cost of Revenue | 38.22 Million | 15.37 Million | 14.91 Million | 10.2 Million | 9.02 Million | 5.89 Million |
| Gross Profit | 14.12 Million | 29.13 Million | 33.6 Million | 17.5 Million | 19.12 Million | 10.79 Million |
| Operating Expenses | 51.01 Million | 52.69 Million | 48.04 Million | 37.58 Million | 40.03 Million | 23.65 Million |
| Selling, General and Administrative Expenses | 29.22 Million | 48.14 Million | 43.72 Million | 33.66 Million | 36.22 Million | 21.18 Million |
| Research and Development Expenses | 4.84 Million | 4.54 Million | 4.32 Million | 3.92 Million | 3.81 Million | 2.46 Million |
| Other Expenses | - | 509 Thousand | -373 Thousand | 479 Thousand | -382 Thousand | -203 Thousand |
| Cost and Expenses | 69.6 Million | 68.07 Million | 62.96 Million | 47.79 Million | 49.06 Million | 29.54 Million |
| Operating Income | -17.25 Million | -23.56 Million | -14.44 Million | -20.08 Million | -20.91 Million | -13.6 Million |
| Interest Expense | 2.47 Million | 15 Thousand | 10 Thousand | 46 Thousand | 8000.00 | 104 Thousand |
| Income Tax Expense | -2.43 Million | 367 Thousand | 380 Thousand | -7.5 Million | -260 Thousand | -3.77 Million |
| Earnings before Tax | -21.28 Million | -22.91 Million | -14.82 Million | -19.4 Million | -19.91 Million | -13.27 Million |
| Net Income | -18.71 Million | -23.27 Million | -15.2 Million | -11.9 Million | -19.65 Million | 64 Million |
| Earnings Per Share Basic | -0.54 | -0.67 | -0.44 | -0.35 | -0.58 | 1.93 |
| Earnings Per Share Diluted | -0.54 | -0.67 | -0.44 | -0.35 | -0.58 | 1.86 |
| Weighted Average Shares Outstanding | 34.62 Million | 34.51 Million | 34.33 Million | 34.21 Million | 34.06 Million | 33.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 34.62 Million | 34.51 Million | 34.33 Million | 34.21 Million | 34.06 Million | 34.36 Million |
| Gross Margin | 0.27 | 0.65 | 0.69 | 0.63 | 0.68 | 0.65 |
| EBIT Margin | -0.35 | -0.51 | -0.31 | -0.70 | -0.71 | -0.78 |
| Profit Margin | -0.36 | -0.52 | -0.31 | -0.43 | -0.70 | 3.84 |
| EBITDA | -18.11 Million | -22 Million | -13.9 Million | -18.47 Million | -19.07 Million | -13.91 Million |
| Earnings Before Tax Margin | -0.33 | -0.53 | -0.30 | -0.72 | -0.74 | -0.82 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 12.14 Million | 14.53 Million | 14.66 Million | 52.34 Million | 15.97 Million | 13.56 Million |
| Cost of Revenue | 9.33 Million | 8.59 Million | 10.6 Million | 38.22 Million | 7.99 Million | 4.29 Million |
| Gross Profit | 2.81 Million | 5.94 Million | 4.06 Million | 14.12 Million | 7.97 Million | 9.27 Million |
| Operating Expenses | 8.35 Million | 6.29 Million | 9.83 Million | 34.07 Million | 6.11 Million | 13.2 Million |
| Selling, General and Administrative Expenses | 6.93 Million | 4.89 Million | 8.59 Million | - | 4.84 Million | 12 Million |
| Research and Development Expenses | 1.42 Million | 1.39 Million | 1.24 Million | - | 1.27 Million | 1.19 Million |
| Other Expenses | -1000.00 | -21 Thousand | -622 Thousand | 622 Thousand | -19 Thousand | 646 Thousand |
| Cost and Expenses | 17.69 Million | 14.88 Million | 20.43 Million | 72.3 Million | 14.11 Million | 17.49 Million |
| Operating Income | -5.54 Million | -6.61 Million | -5.77 Million | -19.95 Million | -4.63 Million | -1.23 Million |
| Interest Expense | 1.42 Million | -1.39 Million | 1.11 Million | 2.47 Million | -585 Thousand | 543 Thousand |
| Income Tax Expense | 50 Thousand | 53 Thousand | 87 Thousand | -2.43 Million | -318 Thousand | 66 Thousand |
| Earnings before Tax | -6.53 Million | -7.53 Million | -9.53 Million | -21.28 Million | -4.99 Million | -953 Thousand |
| Net Income | -6.55 Million | -7.57 Million | -9.6 Million | -18.71 Million | -4.62 Million | -994 Thousand |
| Earnings Per Share Basic | -0.19 | -0.22 | -0.28 | - | -0.13 | -0.03 |
| Earnings Per Share Diluted | -0.19 | -0.22 | -0.28 | - | -0.13 | -0.03 |
| Weighted Average Shares Outstanding | 34.64 Million | 34.64 Million | 34.64 Million | 34.62 Million | 34.64 Million | 34.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 34.64 Million | 34.64 Million | 34.64 Million | 34.62 Million | 34.64 Million | 34.6 Million |
| Gross Margin | 0.23 | 0.41 | 0.28 | 0.27 | 0.50 | 0.68 |
| EBIT Margin | -0.44 | -0.45 | -0.38 | - | -0.29 | -0.23 |
| Profit Margin | -0.54 | -0.52 | -0.66 | -0.36 | -0.29 | -0.07 |
| EBITDA | -5.39 Million | -6.61 Million | -5.62 Million | - | -4.63 Million | -3.1 Million |
| Earnings Before Tax Margin | -0.46 | -0.45 | -0.39 | -0.38 | -0.29 | -0.09 |
300860
AIAGY
AERI3
002829
300017
002948